Miguel Abboud to Adolescent
This is a "connection" page, showing publications Miguel Abboud has written about Adolescent.
Connection Strength
1.678
-
Emergence of gram-negative organisms as the cause of infections in patients with sickle cell disease. Pediatr Blood Cancer. 2021 01; 68(1):e28784.
Score: 0.075
-
Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2020 04 06; 4:CD012389.
Score: 0.072
-
Standard management of sickle cell disease complications. Hematol Oncol Stem Cell Ther. 2020 Jun; 13(2):85-90.
Score: 0.072
-
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
Score: 0.067
-
Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
Score: 0.061
-
Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2017 05 13; 5:CD012389.
Score: 0.059
-
The Daily Experiences of Adolescents in Lebanon With Sickle Cell Disease. J Pediatr Health Care. 2015 Sep-Oct; 29(5):424-34.
Score: 0.051
-
Educational intervention to improve the health outcomes of children with sickle cell disease. J Pediatr Health Care. 2015 Jan-Feb; 29(1):54-60.
Score: 0.049
-
Quality of palliative care in children with cancer in Lebanon. J Med Liban. 2013 Oct-Dec; 61(4):228-36.
Score: 0.046
-
Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
Score: 0.046
-
Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012 Jul; 87(7):678-83.
Score: 0.042
-
Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Rev Hematol. 2011 Jun; 4(3):343-51.
Score: 0.039
-
Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1338-42.
Score: 0.038
-
Wernicke's encephalopathy during total parenteral nutrition in a child with acute lymphoblastic leukemia and acute pancreatitis. Neuropediatrics. 2009 Oct; 40(5):249-51.
Score: 0.036
-
Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer. 2010 Mar; 54(3):398-402.
Score: 0.036
-
Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country. Pediatr Blood Cancer. 2008 Dec; 51(6):787-91.
Score: 0.033
-
Prevention and management of strokes in patients with sickle cell disease. Curr Hematol Rep. 2006 Mar; 5(1):15-22.
Score: 0.027
-
Radiographic predictors of neurocognitive functioning in pediatric Sickle Cell disease. J Child Neurol. 2006 Jan; 21(1):37-44.
Score: 0.027
-
Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
Score: 0.025
-
Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 11; 68(11):e29210.
Score: 0.020
-
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Haematol. 2021 May; 8(5):e334-e343.
Score: 0.019
-
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA. 2021 04 20; 325(15):1513-1523.
Score: 0.019
-
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021 04 01; 96(4):404-417.
Score: 0.019
-
Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000 Nov; 111(2):482-90.
Score: 0.019
-
Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon. PLoS One. 2020; 15(9):e0239258.
Score: 0.019
-
Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon. J Pediatr Hematol Oncol. 2020 08; 42(6):e428-e433.
Score: 0.018
-
Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT). Bone Marrow Transplant. 2020 07; 55(7):1485-1490.
Score: 0.018
-
The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience. Eur J Radiol. 2020 Mar; 124:108855.
Score: 0.018
-
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Contemp Clin Trials. 2019 10; 85:105835.
Score: 0.017
-
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
Score: 0.017
-
Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study. Br J Haematol. 2019 01; 184(2):269-278.
Score: 0.016
-
Isolated delayed metastasis to the talus from Ewing's sarcoma. J Radiol Case Rep. 2018 Aug; 12(8):17-24.
Score: 0.016
-
Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Pharmacogenet Genomics. 2018 08; 28(8):189-195.
Score: 0.016
-
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica. 2018 12; 103(12):2008-2015.
Score: 0.016
-
Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis. Pediatr Blood Cancer. 2018 Jan; 65(1).
Score: 0.015
-
Pediatric cancer pathology review from a single institution: Neuropathology expert opinion is essential for accurate diagnosis of pediatric brain tumors. Pediatr Blood Cancer. 2018 Jan; 65(1).
Score: 0.015
-
Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer. 2017 Dec; 64(12).
Score: 0.015
-
Trends in hematopoietic stem cell transplant activity in Lebanon. Hematol Oncol Stem Cell Ther. 2017 Dec; 10(4):315-320.
Score: 0.015
-
Transient therapy-related myelodysplastic syndrome associated with monosomy 7 and 11q23 translocation. Leukemia. 1997 Mar; 11(3):448-50.
Score: 0.015
-
First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group. Bone Marrow Transplant. 2017 Jan; 52(1):120-125.
Score: 0.014
-
NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon. Pediatr Blood Cancer. 2017 01; 64(1):146-150.
Score: 0.014
-
Effect of Malnutrition at Diagnosis on Clinical Outcomes of Children With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2016 Mar; 38(2):107-10.
Score: 0.014
-
Serum levels of GM-CSF are elevated in patients with thrombocytopenia. Br J Haematol. 1996 Feb; 92(2):486-8.
Score: 0.014
-
Wilms tumor: Successes and challenges in management outside of cooperative clinical trials. Hematol Oncol Stem Cell Ther. 2016 Mar; 9(1):20-5.
Score: 0.013
-
Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med. 2015 Dec 18; 7:130.
Score: 0.013
-
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events. N Engl J Med. 2016 Feb 18; 374(7):625-35.
Score: 0.013
-
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Pediatr Blood Cancer. 2015 Aug; 62(8):1427-36.
Score: 0.013
-
Pain in children and adolescents with sickle cell anemia: a prospective study utilizing self-reporting. Am J Pediatr Hematol Oncol. 1994 Aug; 16(3):219-24.
Score: 0.012
-
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2014 Jul; 89(7):709-13.
Score: 0.012
-
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014 Mar 12; 6(227):227ra33.
Score: 0.012
-
Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma. 2014 Aug; 55(8):1918-21.
Score: 0.012
-
Bone marrow transplantation for sickle cell disease. The United States experience. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):22-6.
Score: 0.012
-
Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon. Pediatr Blood Cancer. 2014 Aug; 61(8):1472-5.
Score: 0.012
-
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60.
Score: 0.011
-
Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol. 2013 Jul; 35(5):356-60.
Score: 0.011
-
Rhabdomyosarcoma treatment and outcome at a multidisciplinary pediatric cancer center in Lebanon. Pediatr Hematol Oncol. 2012 May; 29(4):322-34.
Score: 0.010
-
Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcoma. Skeletal Radiol. 2012 Nov; 41(11):1453-61.
Score: 0.010
-
A preliminary investigation of Beta-hCG expression in patients with osteosarcoma. J Bone Joint Surg Br. 2012 Mar; 94(3):419-24.
Score: 0.010
-
Inherited thrombophilia in childhood arterial stroke: data from Lebanon. Pediatr Neurol. 2011 Sep; 45(3):155-8.
Score: 0.010
-
Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
Score: 0.010
-
Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
Score: 0.010
-
Seven-year experience of using Repiphysis expandable prosthesis in children with bone tumors. Pediatr Blood Cancer. 2010 Sep; 55(3):457-63.
Score: 0.009
-
Severe cerebral vaso-occlusive disease in macrophage activation syndrome. Pediatr Neurol. 2010 Apr; 42(4):283-6.
Score: 0.009
-
Zinc and biotin deficiencies after pancreaticoduodenectomy. Acta Gastroenterol Belg. 2010 Apr-Jun; 73(2):283-6.
Score: 0.009
-
Morvan syndrome following B-cell lymphoma. J Child Neurol. 2010 Aug; 25(8):1038-41.
Score: 0.009
-
The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010; 30:80-3.
Score: 0.009
-
Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution. Pediatr Hematol Oncol. 2009 Sep; 26(6):439-47.
Score: 0.009
-
Abdominal complications of chemotherapy in pediatric malignancies: imaging findings. Clin Imaging. 2009 Jul-Aug; 33(4):253-60.
Score: 0.009
-
Addition of ketamine to propofol for initiation of procedural anesthesia in children reduces propofol consumption and preserves hemodynamic stability. Acta Anaesthesiol Scand. 2008 Apr; 52(4):561-5.
Score: 0.008
-
L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics. 2008 Feb; 39(1):46-50.
Score: 0.008
-
Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007 Jan; 136(2):343-4.
Score: 0.007
-
Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J Pediatr Hematol Oncol. 2006 Mar; 28(3):147-53.
Score: 0.007
-
Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006; 30(2):165-70.
Score: 0.007
-
Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients. Acta Neurochir (Wien). 2006 Feb; 148(2):175-9; discussion 180.
Score: 0.007
-
Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. J Pediatr. 1985 Oct; 107(4):537-41.
Score: 0.007
-
Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin. 2004 May; 28(2):85-102.
Score: 0.006
-
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
Score: 0.006
-
Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics. 2003 Aug; 112(2):324-31.
Score: 0.006
-
Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
Score: 0.005
-
Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9.
Score: 0.005
-
Use of amphotericin B colloidal dispersion in children. J Pediatr Hematol Oncol. 2000 May-Jun; 22(3):242-6.
Score: 0.005
-
Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):389-96.
Score: 0.004
-
Postdural puncture headache in paediatric oncology patients. Can J Anaesth. 1998 Aug; 45(8):741-5.
Score: 0.004
-
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
Score: 0.004
-
Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
Score: 0.004
-
Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42.
Score: 0.004
-
A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13.
Score: 0.003
-
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
Score: 0.003
-
Impact of laparoscopic cholecystectomy on the management of cholelithiasis in children with sickle cell disease. J Pediatr Surg. 1994 Feb; 29(2):209-12; discussion 212-3.
Score: 0.003
-
Five related Lebanese individuals with high plasma lysosomal hydrolases: a new defect in mannose-6-phosphate receptor recognition? Am J Hum Genet. 1984 Sep; 36(5):1001-14.
Score: 0.002